Portable heart monitor for people on FOLFOX chemo
Part of Cancer, Digestive system clinical trials.
This study will use a small portable heart monitor (Holter) to track your heart rhythm while you receive FOLFOX chemotherapy. The goal is to learn more about how the chemotherapy drug 5-FU affects the heart.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a gastrointestinal cancer (like stomach, colon, or rectal cancer).
- You are scheduled to receive FOLFOX chemotherapy (any reason).
- You are 18 years old or older.
- Your heart tracing (ECG) does not have a left bundle branch block or left ventricular hypertrophy with strain.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients receiving a type of chemotherapy called anthracyclines to track how it affects the heart over time. The goal is to learn how to better protect heart health during cancer treatment.
This trial tests a new device that monitors heart health during cancer treatment. It uses a simple on-body sensor alongside your regular echocardiogram to see if it can detect heart changes early.
This study uses wearable heart monitors to check for heart problems during cancer treatment. Participants wear a small patch that tracks their heart rhythm, helping doctors detect issues early.
This study uses a special PET scan to see if chemotherapy can damage the heart early. The goal is to find problems sooner so doctors can protect your heart during cancer treatment.
This trial tests an early heart-focused intervention guided by a special heart recording (impedance cardiography) in people with locally advanced, unresectable stage III non-small cell lung cancer. The goal is to improve heart-related safety during planned radiation and chemotherapy, with or without immunotherapy.
This study tests whether doctors can safely find the best dose of 5-FU, a chemotherapy medicine, for people with advanced gastrointestinal cancers. The goal is to reduce side effects while still treating the cancer effectively.
Hear when a new Gastrointestinal Malignancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.